Literature DB >> 10411647

Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection.

T Flatmark1, B Almås, P M Knappskog, S V Berge, R M Svebak, R Chehin, A Muga, A Martínez.   

Abstract

Kinetic studies of tetrameric recombinant human tyrosine hydroxylase isoform 1 (hTH1) have revealed properties so far not reported for this enzyme. Firstly, with the natural cofactor (6R)-Lerythro-5,6,7, 8-tetrahydrobiopterin (H4biopterin) a time-dependent change (burst) in enzyme activity was observed, with a half-time of about 20 s for the kinetic transient. Secondly, nonhyperbolic saturation behaviour was found for H4biopterin with a pronounced negative cooperativity (0.39 < h < 0.58; [S]0.5 = 24 +/- 4 microM). On phosphorylation of Ser40 by protein kinase A, the affinity for H4biopterin increased ([S]0.5 = 11 +/- 2 microM) and the negative cooperativity was amplified (h = 0.27 +/- 0.03). The dimeric C-terminal deletion mutant (Delta473-528) of hTH1 also showed negative cooperativity of H4biopterin binding (h = 0.4). Cooperativity was not observed with the cofactor analogues 6-methyl-5,6,7,8-tetrahydropterin (h = 0.9 +/- 0.1; Km = 62.7 +/- 5.7 microM) and 3-methyl-5,6,7, 8-tetrahydropterin (H43-methyl-pterin)(h = 1.0 +/- 0.1; Km = 687 +/- 50 microM). In the presence of 1 mM H43-methyl-pterin, used as a competitive cofactor analogue to BH4, hyperbolic saturation curves were also found for H4biopterin (h = 1.0), thus confirming the genuine nature of the kinetic negative cooperativity. This cooperativity was confirmed by real-time biospecific interaction analysis by surface plasmon resonance detection. The equilibrium binding of H4biopterin to the immobilized iron-free apoenzyme results in a saturable positive resonance unit (DeltaRU) response with negative cooperativity (h = 0.52-0.56). Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-hTH1 on binding of H4biopterin and Lerythro-dihydrobiopterin (H2biopterin). Moreover, the ligand-bound forms of the enzyme also showed a decreased resistance to limited tryptic proteolysis. These findings indicate that the binding of H4biopterin at the active site induces a destabilizing conformational change in the enzyme which could be related to the observed negative cooperativity. Thus, our studies provide new insight into the regulation of TH by the concentration of H4biopterin which may have significant implications for the physiological regulation of catecholamine biosynthesis in neuroendocrine cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411647     DOI: 10.1046/j.1432-1327.1999.00445.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis.

Authors:  Poorvi Kaushik; Fredric Gorin; Shireen Vali
Journal:  J Comput Neurosci       Date:  2007-04       Impact factor: 1.621

2.  Substrate-induced conformational transition in human phenylalanine hydroxylase as studied by surface plasmon resonance analyses: the effect of terminal deletions, substrate analogues and phosphorylation.

Authors:  Anne J Stokka; Torgeir Flatmark
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

Review 3.  Phenylalanine hydroxylase misfolding and pharmacological chaperones.

Authors:  Jarl Underhaug; Oscar Aubi; Aurora Martinez
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.

Authors:  Agnete Fossbakk; Rune Kleppe; Per M Knappskog; Aurora Martinez; Jan Haavik
Journal:  Hum Mutat       Date:  2014-06-03       Impact factor: 4.878

5.  Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme.

Authors:  Maria T Bezem; Anne Baumann; Lars Skjærven; Romain Meyer; Petri Kursula; Aurora Martinez; Marte I Flydal
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.